HBZ

gene
On this page

Also known as HBZ1HBZ-T1

Summary

HBZ (hemoglobin subunit zeta, HGNC:4835) is a protein-coding gene on chromosome 16p13.3, encoding Hemoglobin subunit zeta (P02008). The zeta chain is an alpha-type chain of mammalian embryonic hemoglobin.

Zeta-globin is an alpha-like hemoglobin. The zeta-globin polypeptide is synthesized in the yolk sac of the early embryo, while alpha-globin is produced throughout fetal and adult life. The zeta-globin gene is a member of the human alpha-globin gene cluster that includes five functional genes and two pseudogenes. The order of genes is: 5’ - zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 -alpha-1 - theta1 - 3'.

Source: NCBI Gene 3050 — RefSeq curated summary.

At a glance

  • GWAS associations: 14
  • Clinical variants (ClinVar): 18 total
  • Druggable target: yes
  • MANE Select transcript: NM_005332

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4835
Approved symbolHBZ
Namehemoglobin subunit zeta
Location16p13.3
Locus typegene with protein product
StatusApproved
AliasesHBZ1, HBZ-T1
Ensembl geneENSG00000130656
Ensembl biotypeprotein_coding
OMIM142310
Entrez3050

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000252951, ENST00000652335

RefSeq mRNA: 1 — MANE Select: NM_005332 NM_005332

CCDS: CCDS10397

Canonical transcript exons

ENST00000252951 — 3 exons

ExonStartEnd
ENSE00001143658154272154503
ENSE00001143667152644153004
ENSE00003606697153892154096

Expression profiles

Bgee: expression breadth ubiquitous, 117 present calls, max score 87.10.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 4.9859 / max 713.1711, expressed in 97 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
1518552.485979
1518571.968576
1518560.305562
1518540.199948
1518520.01313
1518510.01294

Top tissues by expression

132 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.10silver quality
left testisUBERON:000453378.44gold quality
right testisUBERON:000453478.25gold quality
testisUBERON:000047377.59gold quality
bloodUBERON:000017874.46gold quality
ganglionic eminenceUBERON:000402365.31gold quality
bone marrowUBERON:000237163.60gold quality
bone marrow cellCL:000209259.32silver quality
adrenal tissueUBERON:001830358.23gold quality
subcutaneous adipose tissueUBERON:000219055.24gold quality
anterior cingulate cortexUBERON:000983554.73gold quality
amygdalaUBERON:000187654.72gold quality
temporal lobeUBERON:000187154.71gold quality
ectocervixUBERON:001224954.14gold quality
placentaUBERON:000198753.76gold quality
monocyteCL:000057653.52gold quality
nucleus accumbensUBERON:000188253.28gold quality
right frontal lobeUBERON:000281053.09gold quality
thoracic mammary glandUBERON:000520052.53gold quality
Ammon’s hornUBERON:000195452.12gold quality
leukocyteCL:000073851.89gold quality
cortical plateUBERON:000534351.59gold quality
cerebral cortexUBERON:000095651.17gold quality
dorsolateral prefrontal cortexUBERON:000983451.04gold quality
skin of legUBERON:000151150.88gold quality
primary visual cortexUBERON:000243650.83gold quality
right lungUBERON:000216750.40gold quality
adipose tissueUBERON:000101350.25gold quality
frontal cortexUBERON:000187050.20gold quality
Brodmann (1909) area 9UBERON:001354049.68gold quality

Single-cell (SCXA)

Detected in 11 experiment(s), a significant marker in 10.

ExperimentMarker?Max mean expression
E-MTAB-7407yes208381.29
E-CURD-98yes175477.97
E-HCAD-24yes155061.76
E-HCAD-56yes79912.52
E-MTAB-8205yes13669.02
E-ANND-5yes1060.67
E-MTAB-10042yes43.09
E-MTAB-9388yes9.31
E-MTAB-9067yes6.46
E-HCAD-10yes5.83
E-ANND-3no1.08

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): BCL11A, GATA1, JUN, JUND, RREB1, RUNX1, SP1, ZNF274

miRNA regulators (miRDB)

1 targeting HBZ, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-29B-2-5P99.6768.981726

Literature-anchored findings (GeneRIF, showing 4)

  • Chimeric zeta globin exhibits oxygen binding characteristics which fall within the range observed in adult human and human embryonic hemoglobins. (PMID:11747442)
  • Hb zeta(2)beta(2)(S) exhibits an O(2) affinity as well as a Hill coefficient, Bohr response, and allosteric properties in vitro that are suboptimally suited for physiological O(2) transport in vivo (PMID:15555579)
  • Data indicate a tetranucleotide 3’UTR motif that is required for the high-level accumulation of zeta-globin transcripts in cultured cells, and demonstrate that it prolongs their cytoplasmic half-lives. (PMID:24751163)
  • Assessment of Bcl-xL, TAX, and HBZ Gene Expression in Adult T cell Leukemia/Lymphoma Patients. (PMID:37565279)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusHba-xENSMUSG00000055609
rattus_norvegicusHbzENSRNOG00000020536
drosophila_melanogasterglob1FBGN0027657
caenorhabditis_elegansWBGENE00008996
caenorhabditis_elegansWBGENE00077763

Paralogs (11): HBQ1 (ENSG00000086506), CYGB (ENSG00000161544), HBA2 (ENSG00000188536), HBG2 (ENSG00000196565), MB (ENSG00000198125), HBA1 (ENSG00000206172), HBM (ENSG00000206177), HBE1 (ENSG00000213931), HBG1 (ENSG00000213934), HBD (ENSG00000223609), HBB (ENSG00000244734)

Protein

Protein identifiers

Hemoglobin subunit zetaP02008 (reviewed: P02008)

Alternative names: HBAZ, Hemoglobin zeta chain, Zeta-globin

All UniProt accessions (2): P02008, A0A494C057

UniProt curated annotations — full annotation on UniProt →

Function. The zeta chain is an alpha-type chain of mammalian embryonic hemoglobin.

Subunit / interactions. Heterotetramer of two zeta chains and two epsilon chains in early embryonic hemoglobin Gower-1; two zeta chains and two gamma chains in fetal hemoglobin Portland-1. Heterotetramer of two zeta chains and two beta chains in hemoglobin Portland-2, detected in fetuses and neonates with homozygous alpha-thalassemia.

Tissue specificity. Detected in fetal erythrocytes (at protein level).

Similarity. Belongs to the globin family.

RefSeq proteins (1): NP_005323* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000971GlobinDomain
IPR002338Hemoglobin_a-typFamily
IPR002340Hemoglobin_zetaFamily
IPR009050Globin-like_sfHomologous_superfamily
IPR012292Globin/ProtoHomologous_superfamily
IPR050056Hemoglobin_oxygen_transportFamily

Pfam: PF00042

UniProt features (22 total): helix 10, modified residue 5, turn 2, binding site 2, initiator methionine 1, chain 1, domain 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
3W4UX-RAY DIFFRACTION1.95
1JEBX-RAY DIFFRACTION2.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P02008-F197.890.99

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (2): 59 (distal binding residue); 88 (proximal binding residue)

Post-translational modifications (5): 2, 29, 53, 73, 82

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 98 (showing top): GOBP_MYELOID_CELL_DIFFERENTIATION, GOBP_MYELOID_CELL_HOMEOSTASIS, GOBP_MYELOID_CELL_DEVELOPMENT, GOBP_ERYTHROCYTE_HOMEOSTASIS, ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN, BROWNE_HCMV_INFECTION_48HR_DN, GATA3_01, GOBP_ONE_CARBON_COMPOUND_TRANSPORT, GOBP_GAS_TRANSPORT, GOBP_OXYGEN_TRANSPORT, GATA1_04, WELCH_GATA1_TARGETS, MODULE_88, GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS, GATA1_02

GO Biological Process (5): negative regulation of transcription by RNA polymerase II (GO:0000122), carbon dioxide transport (GO:0015670), oxygen transport (GO:0015671), erythrocyte maturation (GO:0043249), erythrocyte development (GO:0048821)

GO Molecular Function (6): oxygen carrier activity (GO:0005344), iron ion binding (GO:0005506), oxygen binding (GO:0019825), heme binding (GO:0020037), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (3): hemoglobin complex (GO:0005833), haptoglobin-hemoglobin complex (GO:0031838), extracellular exosome (GO:0070062)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
gas transport2
protein-containing complex2
regulation of transcription by RNA polymerase II1
transcription by RNA polymerase II1
negative regulation of DNA-templated transcription1
one-carbon compound transport1
cell maturation1
erythrocyte development1
erythrocyte differentiation1
myeloid cell development1
oxygen transport1
oxygen binding1
molecular carrier activity1
transition metal ion binding1
small molecule binding1
tetrapyrrole binding1
binding1
cation binding1
cytosol1
extracellular vesicle1

Protein interactions and networks

STRING

1058 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HBZSMAD2Q15796909
HBZJUNDP17535886
HBZJUNP05412879
HBZEP300Q09472860
HBZCREB1P16220814
HBZMPGP29372768
HBZCREMQ03060758
HBZKLF1Q13351728
HBZCENPVQ7Z7K6720
HBZFOXP3Q9BZS1624
HBZSMAD3P84022619
HBZPPP1R15AO75807603
HBZHBE1P02100594
HBZATF3P18847581
HBZSOCS2O14508570

IntAct

108 interactions, top by confidence:

ABTypeScore
HBZHBBpsi-mi:“MI:0915”(physical association)0.860
HBBHBZpsi-mi:“MI:0915”(physical association)0.860
HBBHBZpsi-mi:“MI:0407”(direct interaction)0.860
HBZHBDpsi-mi:“MI:0915”(physical association)0.720
HBZHBE1psi-mi:“MI:0915”(physical association)0.680
HBE1HBZpsi-mi:“MI:0407”(direct interaction)0.680
HBZKHDRBS2psi-mi:“MI:0915”(physical association)0.670
HBZNOTCH2NLApsi-mi:“MI:0915”(physical association)0.670
KHDRBS2HBZpsi-mi:“MI:0915”(physical association)0.670
HBZpsi-mi:“MI:0915”(physical association)0.560
KRTAP10-7HBZpsi-mi:“MI:0915”(physical association)0.560
KRTAP10-9HBZpsi-mi:“MI:0915”(physical association)0.560
KRT40HBZpsi-mi:“MI:0915”(physical association)0.560
HBZDOCK8psi-mi:“MI:0915”(physical association)0.560
HBZKRTAP10-7psi-mi:“MI:0915”(physical association)0.560
HBZKRTAP10-9psi-mi:“MI:0915”(physical association)0.560
HBZKRT40psi-mi:“MI:0915”(physical association)0.560

BioGRID (58): HBZ (Two-hybrid), DOCK8 (Two-hybrid), KRT40 (Two-hybrid), KHDRBS2 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), HBZ (Affinity Capture-MS), SIRT5 (Affinity Capture-MS), HBZ (Affinity Capture-MS), HBZ (Affinity Capture-MS), MYO18A (Affinity Capture-MS), CUL1 (Affinity Capture-Western), HBZ (Affinity Capture-MS)

ESM2 similar proteins: A2XE98, C0HJT7, I1LJI1, I3SPW2, K7N5M6, O04985, O04986, O13163, O13164, O24520, O93348, P02008, P02140, P02141, P06347, P07803, P13786, P23018, P23244, P45721, P45722, P68168, P68169, P80727, P82345, P83272, P83273, P83614, P83625, P84652, P85082, Q3C1F3, Q3C1F4, Q42785, Q42831, Q575S8, Q575S9, Q90485, Q90486, Q91473

Diamond homologs: A1A4Q3, B3EWD1, B3EWE1, B3EWE3, O12985, P01942, P01943, P01944, P01945, P01946, P01947, P01950, P01964, P01967, P01975, P01977, P01978, P01979, P01980, P01983, P01990, P01993, P02001, P02002, P02003, P02005, P02006, P02007, P02008, P02009, P02011, P04237, P04238, P04239, P04240, P04241, P04242, P04243, P04442, P06347

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 51 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
oxygen transport6143.6×6e-10
erythrocyte development671.8×3e-08

Disease & clinical

Clinical variants and AI predictions

ClinVar

18 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance15
Likely benign1
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

237 predictions. Top by Δscore:

VariantEffectΔscore
16:153002:GAG:Gdonor_gain1.0000
16:153005:GT:Gdonor_loss1.0000
16:153006:T:Gdonor_loss1.0000
16:153888:CCAG:Cacceptor_loss1.0000
16:153890:A:AGacceptor_gain1.0000
16:153890:A:Tacceptor_loss1.0000
16:153891:G:GGacceptor_gain1.0000
16:153891:GGCT:Gacceptor_gain1.0000
16:153891:GGCTC:Gacceptor_gain1.0000
16:153945:ACCCG:Aacceptor_gain1.0000
16:154093:CAAG:Cdonor_loss1.0000
16:154094:AAGG:Adonor_loss1.0000
16:154095:AG:Adonor_gain1.0000
16:154095:AGGT:Adonor_loss1.0000
16:154096:GG:Gdonor_gain1.0000
16:154097:GTGC:Gdonor_loss1.0000
16:153000:GAGAG:Gdonor_gain0.9900
16:153005:G:GGdonor_gain0.9900
16:153890:AG:Aacceptor_gain0.9900
16:153891:GG:Gacceptor_gain0.9900
16:153891:GGC:Gacceptor_gain0.9900
16:153945:ACCC:Aacceptor_gain0.9900
16:154097:G:GGdonor_gain0.9900
16:154270:A:AGacceptor_gain0.9900
16:154271:G:GGacceptor_gain0.9900
16:154266:CCCCA:Cacceptor_loss0.9800
16:154267:CCCAG:Cacceptor_loss0.9800
16:154268:CCAG:Cacceptor_loss0.9800
16:154269:CAGC:Cacceptor_loss0.9800
16:154271:GCTC:Gacceptor_gain0.9800

AlphaMissense

917 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:154091:T:CF99L0.994
16:154093:C:AF99L0.994
16:154093:C:GF99L0.994
16:153926:T:CF44L0.991
16:153928:C:AF44L0.991
16:153928:C:GF44L0.991
16:154058:C:GH88D0.988
16:154062:C:AA89D0.988
16:154347:T:AW126R0.985
16:154347:T:CW126R0.985
16:152986:G:AG26D0.983
16:154005:C:AA70E0.983
16:153975:G:AG60D0.982
16:153927:T:CF44S0.981
16:154058:C:AH88N0.981
16:154092:T:CF99S0.981
16:154060:C:AH88Q0.980
16:154060:C:GH88Q0.980
16:154090:C:AN98K0.980
16:154090:C:GN98K0.980
16:154395:C:AR142S0.978
16:154004:G:CA70P0.977
16:153927:T:GF44C0.976
16:154392:T:CY141H0.976
16:154080:A:GD95G0.974
16:154092:T:GF99C0.973
16:154074:G:CR93P0.970
16:154083:C:AP96Q0.970
16:153971:C:GH59D0.969
16:154396:G:CR142P0.969

dbSNP variants (sampled 300 via entrez): RS1000689351 (16:150820 T>G), RS1000741228 (16:151018 T>C), RS1001607930 (16:151756 C>G), RS1001995715 (16:154386 G>A,C,T), RS1002031558 (16:153223 GAGGACAGATAGCGTTCCCTCTCAGTGAGGAGAGCAGGGTA>G), RS1002060106 (16:152058 A>C,T), RS1002344905 (16:153142 G>A,T), RS1005617977 (16:152533 T>C), RS1006023332 (16:152456 G>C), RS1006102427 (16:151329 A>G), RS1006211552 (16:151583 C>G,T), RS1006675968 (16:151440 T>A), RS1007102327 (16:152005 G>A), RS1007785549 (16:154993 A>G), RS1008158580 (16:151315 G>C)

Disease associations

OMIM: gene MIM:142310 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

14 associations (top):

StudyTraitp-value
GCST003122_1Hemoglobin levels6.000000e-18
GCST004602_219Mean corpuscular volume8.000000e-15
GCST004630_167Mean corpuscular hemoglobin1.000000e-33
GCST005951_12Body mass index5.000000e-11
GCST005992_20Mean corpuscular hemoglobin concentration7.000000e-30
GCST005993_12Mean corpuscular hemoglobin2.000000e-78
GCST005996_2Red blood cell count2.000000e-12
GCST006011_44Mean corpuscular volume5.000000e-55
GCST006585_1712Blood protein levels2.000000e-10
GCST008991_6Early cardiac repolarization1.000000e-06
GCST90002384_352Hemoglobin2.000000e-12
GCST90002390_626Mean corpuscular hemoglobin6.000000e-17
GCST90002403_655Red blood cell count1.000000e-22
GCST90002403_656Red blood cell count1.000000e-17

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0004509hemoglobin measurement
EFO:0007629hemoglobin A1 measurement
EFO:0004527mean corpuscular hemoglobin
EFO:0004340body mass index
EFO:0004528mean corpuscular hemoglobin concentration
EFO:0004305erythrocyte count
EFO:0004885early cardiac repolarization measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6066981 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
6.28Kd522.1nMCHEMBL5653589
6.28ED50522.1nMCHEMBL5653589

PubChem BioAssay actives

1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2148490: Binding affinity to human HBZ incubated for 45 mins by Kinobead based pull down assaykd0.5221uM

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, increases methylation, affects cotreatment2
2,4,6-tribromophenoldecreases expression1
decabromobiphenyl etherdecreases expression1
tetrabromobisphenol Adecreases expression1
thrombin receptor-activating peptide SFLLRNPNDKYincreases secretion1
entinostatdecreases expression1
pentabrominated diphenyl ether 100decreases expression1
Benzo(a)pyrenedecreases methylation, increases methylation1
Hydralazineaffects cotreatment, decreases expression1
Hydrogen Peroxidedecreases expression, increases expression1
T-2 Toxinincreases expression1
Aflatoxin B1decreases methylation1
Butyric Acidincreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5651532BindingBinding affinity to human HBZ incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.